News
VYCO
0.057
NaN%
--
Vycor Medical swings to Q1 FY26 profit of $20,108; revenue rises 5% to $458,540
PUBT · 05/15 18:53
Vycor Medical FY25 revenue rises 17% to USD 1.9 million
Reuters · 03/31 19:48
Vycor Medical Reports 31% Increase in Third-Quarter Revenue
Reuters · 11/14/2025 16:25
Weekly Report: what happened at VYCO last week (0908-0912)?
Weekly Report · 09/15/2025 10:33
NovaSource, an Affiliate of Clairvest Group Inc., Launches AI-Powered NovaVision Platform for Solar Optimization
Reuters · 09/08/2025 13:01
Weekly Report: what happened at VYCO last week (0901-0905)?
Weekly Report · 09/08/2025 10:35
Weekly Report: what happened at VYCO last week (0825-0829)?
Weekly Report · 09/01/2025 10:31
Weekly Report: what happened at VYCO last week (0818-0822)?
Weekly Report · 08/25/2025 10:39
Weekly Report: what happened at VYCO last week (0811-0815)?
Weekly Report · 08/18/2025 10:33
Weekly Report: what happened at VYCO last week (0804-0808)?
Weekly Report · 08/11/2025 10:39
Vycor Medical Inc. Reports 24% Revenue Increase and Break-Even EPS for Q2 2025, Achieves $23,887 Net Income
Reuters · 08/08/2025 16:49
Weekly Report: what happened at VYCO last week (0728-0801)?
Weekly Report · 08/04/2025 10:41
More
Webull provides a variety of real-time VYCO stock news. You can receive the latest news about Vycor Med Inc through multiple platforms. This information may help you make smarter investment decisions.
About VYCO
Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company designs, develops and markets neurological medical devices and therapies. The Company operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage, such as that caused by a stroke. Vycor Medical’s ViewSite Brain Access System (VBAS) is a next-generation retraction and access system. VBAS is a minimally invasive neurosurgical device designed to improve access to brain lesions while reducing tissue damage and enhancing patient outcomes. The VBAS system is used in over 300 hospitals in the United States and in numerous countries internationally. NovaVision products include Visual Restoration Therapy (VRT) and NeuroEyeCoach.